Podcast: PharmaSource Podcast
Episode: Alkermes’ 9 KPIs That Drive Successful CDMO Management — featured guest Stephen Sheehan of Alkermes. Apple Podcasts
Original Episode Link: Listen here Apple Podcasts
1. Executive Summary
Stephen Sheehan, Director of External Development & Manufacturing at Alkermes, walks through how a significant batch failure triggered the development of a comprehensive governance framework for CDMO partnerships. He discusses how Alkermes implemented nine critical KPIs to manage external manufacturing, how they built sustainable relationships with CDMO partners, and the operational discipline required to maintain quality, timeline certainty, and cost-control.
2. Key Takeaways for CDMOs
- Risk events drive change: The batch failure was the catalyst, showing that reactive events often force proactive frameworks.
- KPI governance matters: Couponing CDMO performance with structured, meaningful KPIs (= quality, on-time delivery, data integrity, cost variance) enables accountability.
- Partnership mindset vs vendor mindset: Alkermes emphasizes partnerships where CDMO is treated as an extension of internal operations, not just a supplier.
- Sustainability and cost are linked: Disciplined execution and transparency were as important as cost reductions; sustainability in outsourcing requires governance, not just contracts.
3. What This Means for the Industry
In the CDMO/sponsor interface, what’s often missing isn’t capacity but governance and metrics maturity. As sponsors outsource more complex modalities with higher risk (cell & gene, personalized medicines), the ability to structure, monitor, and enforce CDMO performance via KPIs becomes a differentiator. CDMOs that can show not just “we deliver batches” but “we deliver under governance,” will win more of the next-gen outsourcing business.
4. CDMOWorld Commentary
From our vantage, this episode underscores a gap many CDMOs overlook: the governance layer. It’s not only about building capacity or tech; it’s about aligning partner metrics, creating shared frameworks, and managing risk-to-outcome, not cost-to-unit. If you’re a CDMO, ask: What KPIs do we bring to our sponsors? How transparent are they? How quickly do we react when we miss them? If you’re a biotech/ pharma sponsor, ask: Does our CDMO partner operate with our KPIs or only theirs?
5. Useful Links
Source: PharmaSource Podcast (© Life Science Networks). Summary and analysis by CDMOWorld.com.